Innovative Cellular Therapeutics Holdings Ltd, 10% owner at Lyell Immunopharma, sold LYEL on Jul 16, 2026
Data as of Oct 16
▼ SELL$13710 shares at $13.73Innovative Cellular Therapeutics Holdings Ltd 10% ownerLYEL Lyell Immunopharma, Inc.
- Traded
- Jul 16, 2026
- Disclosed
- Jul 17, 2026
- Filed
- 1 day after the trade
Form 4s are due within two business days.
Official filing (SEC Form 4) ↗
The price around the disclosure
LYEL since disclosure
−39.0%
after the sale
Similar stocks (XLV) since disclosure
+9.7%
XLV — its sector index fund
Change in closing price from Jul 17, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.
Our take
None of our tested rules fired on this trade.